Elevance Health ELV
Elevance Health is a US health insurer offering commercial and government health plans (Medicare and Medicaid), as well as pharmaceutical and digital health services. Elevance Health shows solid financial health (score 6.56) with net cash, but its growth is weak (revenue +1.4%, earnings -13.1%) and its valuation is average (P/E 17.51), suggesting a defensive profile without clear catalysts.
Detailed metrics
Market and fundamental data as of the analysis date.
Full AI report
Generated automatically from the metrics, the macro context and the company's news.
Elevance Health is a US health insurer offering commercial and government health plans (Medicare and Medicaid), as well as pharmaceutical and digital health services. Elevance Health shows solid financial health (score 6.56) with net cash, but its growth is weak (revenue +1.4%, earnings -13.1%) and its valuation is average (P/E 17.51), suggesting a defensive profile without clear catalysts.
Score by category
| Category | Score |
|---|---|
| Financial health | 6.6 |
| Quality / Moat | 5.2 |
| Valuation | 6.7 |
| Growth | 3.4 |
| Dividend | 6.1 |
| Momentum | 6.6 |
| Risk & Context | 7.1 |
OVERALL SCORE: 5.9/10
Context and risks
Moderate regulatory risk in the U.S. health insurance sector (pressure on Medicare Advantage pricing and rate reviews), which could impact Elevance's margins.
News considered in the analysis
- 3 U.S. Dividend Stocks Offering Defensive Income as Fed Rate Pressure Persists — Listículo genérico sin información específica sobre Elevance Health.
- What Should CVS Stock Investors Be Watching Now? — Noticia sobre un competidor (CVS), sin impacto directo en los fundamentales de Elevance.
- Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Podcast — Promoción de un modelo alternativo de salud (healthsharing), sin relevancia material para Elevance.
- Did UnitedHealth Name The Fix Before Its Stock Ran? — Análisis sobre UnitedHealth, un competidor, sin implicaciones directas para Elevance.
- Can UNH Stock Keep Growing Earnings While Its Sales Stall? — Análisis sobre UnitedHealth, sin información nueva sobre Elevance.
Verdict: Hold; financial stability and a moderate dividend provide support, but lack of growth limits upside potential.
Main risk: The main risk is regulatory pressure on Medicare Advantage pricing and government reimbursements, which could further compress already low operating margins (4.56%).
Other Healthcare companies
Neighbours in the sector ranking, to compare without going back to the index.
See all 1,000+ companies in the index →